Robin Tranchant

Dissecting heterogeneity in malignant pleural mesothelioma through histo-molecular gradients for clinical applications

Yuna Blum, Clément Meiller, Lisa Quetel et al. · Nature Communications · 2019 · 197 citations · Full text

Genetic alterations of malignant pleural mesothelioma: association with tumor heterogeneity and overall survival

Lisa Quetel, Clément Meiller, Jean‐Baptiste Assié et al. · Molecular Oncology · 2020 · 112 citations · Full text

Molecular Heterogeneity, Malignant Pleural Mesothelioma, Mpm Heterogeneity +15

Co-occurring Mutations of Tumor Suppressor Genes, <i>LATS2</i> and <i>NF2</i> , in Malignant Pleural Mesothelioma

Robin Tranchant, Lisa Quetel, Anne Tallet et al. · Clinical Cancer Research · 2016 · 78 citations · Full text

Combined MEK and PI3K/p110β Inhibition as a Novel Targeted Therapy for Malignant Mesothelioma Displaying Sarcomatoid Features

Miriam Marqués, Robin Tranchant, Blanca Risa-Ebrí et al. · Cancer Research · 2020 · 30 citations · Full text

Assessment of signaling pathway inhibitors and identification of predictive biomarkers in malignant pleural mesothelioma

Robin Tranchant, Lisa Quetel, François Montagne et al. · Lung Cancer · 2018 · 15 citations · Full text

Prognostic Biomarkers, Pathway Inhibitors, Malignant Pleural Mesothelioma +7